ID: ALA4569451

Max Phase: Preclinical

Molecular Formula: C14H10N4O2

Molecular Weight: 266.26

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1ccc(-c2cn(-c3cccnc3)nn2)cc1

Standard InChI:  InChI=1S/C14H10N4O2/c19-14(20)11-5-3-10(4-6-11)13-9-18(17-16-13)12-2-1-7-15-8-12/h1-9H,(H,19,20)

Standard InChI Key:  CALAFEGXXZJBTB-UHFFFAOYSA-N

Associated Targets(non-human)

ORF 73 309 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 266.26Molecular Weight (Monoisotopic): 266.0804AlogP: 2.03#Rotatable Bonds: 3
Polar Surface Area: 80.90Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.80CX Basic pKa: 4.84CX LogP: 1.25CX LogD: -0.99
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.78Np Likeness Score: -1.63

References

1. Kirsch P, Jakob V, Oberhausen K, Stein SC, Cucarro I, Schulz TF, Empting M..  (2019)  Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8.,  62  (8): [PMID:30888817] [10.1021/acs.jmedchem.8b01827]
2. Kirsch P,Stein SC,Berwanger A,Rinkes J,Jakob V,Schulz TF,Empting M.  (2020)  Hit-to-lead optimization of a latency-associated nuclear antigen inhibitor against Kaposi's sarcoma-associated herpesvirus infections.,  202  [PMID:32634628] [10.1016/j.ejmech.2020.112525]

Source